相关实验视频
Updated: Jul 16, 2025

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.2K
在复发性妇产科医生癌症中使用先进的支臂疗法技术进行再照射
Umesh Mahantshetty1, Sheetal R Kashid2, Gargee Mulye2
1Department of Radiation Oncology, Homi Bhabha Cancer Hospital, Visakhapatnam, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Brachytherapy
|September 16, 2023
概括
先进的支臂疗法 (BT) 再辐射是复发性妇科癌症的可行和安全的选择. 这项技术改善了宫,子宫内膜和阴道癌患者的局部控制和生存率.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 妇科瘤学 妇科瘤学
背景情况:
- 复发的妇科癌症往往需要重新照射.
- 先进的支臂疗法 (BT) 技术为重新治疗提供了新的可能性.
研究的目的:
- 为了评估复发性妇科癌症的临床结果,使用先进的支臂疗法 (BT) 进行再辐射治疗 (reRT).
主要方法:
- 追溯分析76名患有复发性妇科癌症的妇女,接受了reRT和BT治疗.
- 分析了患者,疾病和治疗特征.
- 用Kaplan-Meier方法进行生存分析.
主要成果:
- 在39个月的中位随访期内,2年局部控制 (LC),无进展生存 (PFS) 和整体生存 (OS) 分别为60%,56.3%和72.9%.
- 接受BT剂量>40 Gy的患者表现出更高的LC和PFS.
- 3-4级晚期毒性包括直肠 (13%),膀 (8%) 和阴道纤维化 (31%).
结论:
- 先进的BT再辐射是一种可行且安全的治疗,用于复发的宫癌,子宫内膜癌和阴道癌.
- 这种方法可以实现有利的局部控制和生存结果.
更多相关视频
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.4K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K